Phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM)

被引:5
|
作者
Nowak, A. K. [1 ]
Millward, M. J. [1 ]
Francis, R. [1 ]
van der Schaaf, A. [1 ]
Musk, A. W. [1 ]
Byrne, M. J. [1 ]
机构
[1] Sir Charles Gairdner Hosp, Perth, WA, Australia
关键词
D O I
10.1200/jco.2008.26.15_suppl.8063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8063
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052
    O'Brien, Mary
    Gaafar, Rabab Mohamed
    Popat, Sanjaykumar
    Grossi, Francesco
    Price, Allan
    Talbot, Denis Charles
    Cufer, Tanja
    Ottensmeier, Christian H. H.
    Danson, Sarah
    Pallis, Athanasios G.
    Hasan, Baktiar
    Van Meerbeeck, Jan P.
    Baas, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] SECOND-LINE THERAPY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. FRENCH RETROSPECTIVE STUDY 2005-2006
    Margery, Jacques
    Ruffie, Pierre
    Le Floch, Herve
    Planchard, David
    Riviere, Frederic
    Gaspard, Wanda
    Saint Blancard, Patrick
    Besse, Benjamin
    Vaylet, Fabien
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1364 - S1365
  • [43] Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)
    Margery, J.
    Riviere, F.
    Planchard, D.
    Le Floch, H.
    Ferrand, F. -R.
    Mairovitz, A.
    Besse, B.
    Vaylet, F.
    Ruffie, P.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2010, 66 (04) : 255 - 259
  • [44] Vinorelbine as Second or Third-Line Therapy in Pemetrexed-Pretreated Malignant Pleural Mesothelioma (MPM) Patients
    Ceresoli, Giovanni L.
    Zucali, Paolo A.
    Grosso, Federica
    Mencoboni, Manlio
    Bonomi, Philip
    Parra, Hector J. M. Soto
    Pasello, Giulia
    Cortinovis, Diego
    Perrino, Matteo
    Muzio, Alberto
    Bruzzone, Andrea
    De Vincenzo, Fabio
    Degiovanni, Daniela
    Simonelli, Matteo
    Beretta, Giordano D.
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [45] Malignant pleural mesothelioma (MPM) genomic profile in the randomized phase II RAMES Study.
    Pagano, Maria
    Gnoni, Roberta
    Bonelli, Candida
    Zanelli, Francesca
    Garassino, Marina Chiara
    Ceresoli, Giovanni Luca
    Pasello, Giulia
    Tiseo, Marcello
    Parra, Hector J. Soto
    Grosso, Federica
    Zucali, Paolo Andrea
    Torricelli, Federica
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Vinorelbine as second or third-line therapy in pemetrexed-pretreated malignant pleural mesothelioma (MPM) patients
    Ceresoli, G. L.
    Zucali, P. A.
    Grosso, F.
    Mencoboni, M.
    Sauta, M. G.
    Soto Parra, H. J.
    Pasello, G.
    Cortinovis, D.
    Perrino, M.
    Muzio, A.
    Bruzzone, A.
    De Vincenzo, F.
    Degiovanni, D.
    Bonomi, M.
    Simonelli, M.
    Beretta, G. D.
    Giordano, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [47] RAMES trial: A multicentre, double-blind, randomized, phase II study on gemcitabine plus ramucirumab versus gemcitabine alone as second-line treatment for advanced malignant pleural mesothelioma (MPM)
    Pagano, M.
    Ceresoli, G. L.
    Zucali, P. A.
    Pasello, G.
    Garassino, M. C.
    Grosso, F.
    Tiseo, M.
    Parra, H. J. Soto
    Zanelli, F.
    Cappuzzo, F.
    Grossi, F.
    De Marinis, F.
    Pedrazzoli, P.
    Bonelli, C.
    Berselli, A.
    Normanno, N.
    Pinto, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1078 - S1078
  • [48] Second line therapy in malignant pleural mesothelioma: A systematic review
    Buikhuisen, Wieneke A.
    Hiddingab, Birgitta I.
    Baas, Paul
    van Meerbeeck, Jan P.
    LUNG CANCER, 2015, 89 (03) : 223 - 231
  • [49] Phase II trial of ZD0473 as second-line therapy in mesothelioma
    Giaccone, G
    O'Brien, MER
    Byrne, MJ
    Bard, M
    Kaukel, E
    Smit, B
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S19 - S24
  • [50] Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
    Zucali, P. A.
    Simonelli, M.
    Michetti, G.
    Tiseo, M.
    Ceresoli, G. L.
    Collova, E.
    Follador, A.
    Lo Dico, M.
    Moretti, A.
    De Vincenzo, F.
    Lorenzi, E.
    Perrino, M.
    Giordano, L.
    Farina, G.
    Santoro, A.
    Garassino, M.
    LUNG CANCER, 2012, 75 (03) : 360 - 367